Literature DB >> 26044619

The group II metabotropic glutamate receptor agonist LY379268 reduces toluene-induced enhancement of brain-stimulation reward and behavioral disturbances.

Ming-Huan Chan1, Yi-Ling Tsai, Mei-Yi Lee, Astrid K Stoker, Athina Markou, Hwei-Hsien Chen.   

Abstract

RATIONALE: Toluene, a widely abused solvent with demonstrated addictive potential in humans, hasbeen reported to negatively modulate N-methyl-D-aspartate receptors (NMDARs) and alter glutamatergicneurotransmission. The group II metabotropic glutamate receptor (mGluR) agonist LY379268 has beenshown to regulate glutamate release transmission and NMDAR function and block toluene-induced locomotorhyperactivity. However, remaining unknown is whether group II mGluRs are involved in the toluene-induced reward-facilitating effect and other behavioral manifestations.
OBJECTIVES: The present study evaluated the effects of LY379268 on toluene-induced reward enhancement, motor incoordination, recognition memory impairment, and social interaction deficits.
RESULTS: Our data demonstrated that LY379268 significantly reversed the toluene-induced lowering of intracranial self-stimulation (ICSS) thresholds and impairments in novel object recognition, rotarod performance, and social interaction with different potencies.
CONCLUSIONS: These results indicate a negative modulatory role of group II mGluRs in acute toluene-induced reward-facilitating and behavioral effects and suggest that group II mGluR agonists may have therapeutic potential for toluene addiction and the prevention of toluene intoxication caused by occupational or intentional exposure.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26044619      PMCID: PMC4536139          DOI: 10.1007/s00213-015-3973-3

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  57 in total

1.  Group II metabotropic glutamate receptors enhance NMDA receptor currents via a protein kinase C-dependent mechanism in pyramidal neurones of rat prefrontal cortex.

Authors:  Joanna P Tyszkiewicz; Zhenglin Gu; Xun Wang; Xiang Cai; Zhen Yan
Journal:  J Physiol       Date:  2003-11-28       Impact factor: 5.182

2.  Facilitation of electrical brain self-stimulation behavior by abused solvents.

Authors:  Anton Bespalov; Irina Sukhotina; Ivan Medvedev; Andrey Malyshkin; Irina Belozertseva; Robert Balster; Edwin Zvartau
Journal:  Pharmacol Biochem Behav       Date:  2003-04       Impact factor: 3.533

3.  Metabotropic glutamate receptor 5 modulates behavioral and hypothermic responses to toluene in rats.

Authors:  Ming-Huan Chan; Chia-Chi Lee; Bih-Fen Lin; Chia-Yen Wu; Hwei-Hsien Chen
Journal:  Pharmacol Biochem Behav       Date:  2012-09-29       Impact factor: 3.533

4.  The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats.

Authors:  J Cartmell; J A Monn; D D Schoepp
Journal:  J Pharmacol Exp Ther       Date:  1999-10       Impact factor: 4.030

5.  Toluene impairs learning and memory, has antinociceptive effects, and modifies histone acetylation in the dentate gyrus of adolescent and adult rats.

Authors:  Alejandra Huerta-Rivas; Carolina López-Rubalcava; Sinthia L Sánchez-Serrano; Mariana Valdez-Tapia; Mónica Lamas; Silvia L Cruz
Journal:  Pharmacol Biochem Behav       Date:  2012-03-31       Impact factor: 3.533

6.  Systemic pre-treatment with a group II mGlu agonist, LY379268, reduces hyperalgesia in vivo.

Authors:  E F Sharpe; A E Kingston; D Lodge; J A Monn; P M Headley
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

7.  Cannabidiol and clozapine reverse MK-801-induced deficits in social interaction and hyperactivity in Sprague-Dawley rats.

Authors:  Anand Gururajan; David A Taylor; Daniel T Malone
Journal:  J Psychopharmacol       Date:  2012-04-09       Impact factor: 4.153

8.  Adolescent toluene exposure produces enduring social and cognitive deficits in mice: an animal model of solvent-induced psychosis.

Authors:  Bih-Fen Lin; Mei-Chun Ou; Shiang-Sheng Chung; Cheng-Yoong Pang; Hwei-Hsien Chen
Journal:  World J Biol Psychiatry       Date:  2010-09       Impact factor: 4.132

9.  In vitro and in vivo evidence for a lack of interaction with dopamine D2 receptors by the metabotropic glutamate 2/3 receptor agonists 1S,2S,5R,6S-2-aminobicyclo[3.1.0]hexane-2,6-bicaroxylate monohydrate (LY354740) and (-)-2-oxa-4-aminobicyclo[3.1.0] Hexane-4,6-dicarboxylic acid (LY379268).

Authors:  Matthew J Fell; Kenneth W Perry; Julie F Falcone; Bryan G Johnson; Vanessa N Barth; Karen S Rash; Virginia L Lucaites; Penny G Threlkeld; James A Monn; David L McKinzie; Gerard J Marek; Kjell A Svensson; David L Nelson
Journal:  J Pharmacol Exp Ther       Date:  2009-09-15       Impact factor: 4.030

10.  Group II mGlu receptor activation suppresses norepinephrine release in the ventral hippocampus and locomotor responses to acute ketamine challenge.

Authors:  Daniel S Lorrain; Hervé Schaffhauser; Una C Campbell; Christopher S Baccei; Lucia D Correa; Blake Rowe; Dana E Rodriguez; Jeffery J Anderson; Mark A Varney; Anthony B Pinkerton; Jean-Michel Vernier; Linda J Bristow
Journal:  Neuropsychopharmacology       Date:  2003-06-25       Impact factor: 7.853

View more
  1 in total

1.  Negative allosteric modulation of GABAA receptors inhibits facilitation of brain stimulation reward by drugs of abuse in C57BL6/J mice.

Authors:  Matthew E Tracy; Matthew L Banks; Keith L Shelton
Journal:  Psychopharmacology (Berl)       Date:  2015-11-27       Impact factor: 4.530

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.